Are you using or planning to use RNAseq in your research? If so, please help us understand your needs! Complete the global survey on RNAseq and find out how your fellow scientists are applying RNAseq technology in their research. Take the survey!
Numerous studies have concluded that it takes an average of 17 years for basic research discoveries to be translated into clinical practice (1). In the path from bench to bedside, however, not every discovery will fall within that middle range. Some take quite a bit longer, as in the case of circulating tumor cells (CTCs)… Read article →
ASHG 2015, the annual meeting of The American Society of Human Genetics, is taking place next week from Oct. 6–10 in Baltimore, Maryland. If you’re coming, we’d love to see you at our booths, 1621 and 1622! Booth 1621 will focus on QIAGEN’s sample-to-insight solutions for some of the topics we discuss here at Biomarker Insights, including liquid biopsy… Read article →
Precision medicine offers to transform patient care by targeting treatment to those with the most to gain. To date, the most significant advances have been at the DNA level. Development of RNA expression signatures as biomarkers has been more problematic. While RNA expression analysis has yielded valuable insights into the biological mechanisms of disease, RNA… Read article →
Whether you’re studying single cell genomics, circulating tumor cells or the microbiome, analyzing single cells creates the potential for a deeper understanding of cell heterogeneity. But several challenges stand in the way of this goal, such as allelic dropout, coverage uniformity and low yield. How can you overcome these? The single cell team at QIAGEN… Read article →